Journal of Gastroenterology

, Volume 31, Issue 4, pp 552–558 | Cite as

Multivariate analysis of risk factors for hepatocellular carcinoma in patients with hepatitis C virus-related liver cirrhosis

  • Toshiya Chiba
  • Yasushi Matsuzaki
  • Masato Abei
  • Junichi Shoda
  • Tatsuya Aikawa
  • Naomi Tanaka
  • Toshiaki Osuga
Liver, Pancreas, and Biliary Tract

Abstract

To elucidate the risk factors for hepatocellular carcinoma (HCC) in hepatitis C virus (HCV)-related liver cirrhosis (LC), we examined 204 cirrhotic patients negative for hepatitis B surface antigen and positive for HCV antibodies. The independent influence of various clinical characteristics in these patients was analyzed by multiple logistic regression, and the risk factors for HCC were identified. Multiple logistic regression analysis identified and ranked the following four risk factors: male sex (P<0.001), habitual heavy drinking (P<0.005), hepatitis B virus antibody positivity (anti-HBs and/or anti-HBc,P<0.05), and age greater than 60 years (P<0.05). The odds ratio of HCC was 4.20 (95% confidence interval; CI, 1.80–9.78) in male patients, 3.27 (95% CI, 1.46–7.30) in habitual heavy drinkers, 2.01 (95% CI, 1.01–3.99) in patients positive for hepatitis B virus antibodies, and 2.06 (95% CI, 1.00–4.23) in patients older than 60 years. The cumulative occurrence rates of HCC after blood transfusion were significantly higher in habitual heavy drinkers (4.8%, 49.4%, and 74.7% at 10, 20, and 30 years, respectively) than in non-drinkers (0%, 21.0%, and 23.3% at 10, 20, and 30 years, respectively,P<0.0003). The mean interval for progression to LC after blood transfusion was significantly shorter in the habitual heavy drinkers than in the non-drinkers (22.4±4.4 years vs 28.4±3.9 years;P<0.0003). This multivariate analysis revealed that habitual heavy drinking and hepatitis B virus antibody positivity are significant risk factors for HCC in HCV-related liver cirrhosis.

Key words

hepatocellular carcinoma hepatitis C virus hepatitis B virus alcohol drinking 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Parkin DM, Stjernsward J, Muir CS. Estimates of the worldwide frequency of 12 major cancers. Bull WHO 1984;62:162–182.Google Scholar
  2. 2.
    Linsell DA, Hibbinson J. The geographic pathology of liver cell cancer. In: Cameron HM, Linsell DA, Warwick GP (eds). Liver cell cancer. New York: Elsevier, 1976;1–16.Google Scholar
  3. 3.
    Beasley RP. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma: Epidemiologic considerations. Hepatology 1982; 2(Suppl):21–26.Google Scholar
  4. 4.
    Kew M, Popper H. Relationship between hepatocellular carcinoma and cirrhosis. Semin Liver Dis 1984;4:136–146.PubMedGoogle Scholar
  5. 5.
    Beasley RP, Hwang LY. Hepatocellular carcinoma and hepatitis B virus. Semin Liver Dis 1984;4:113–121.PubMedGoogle Scholar
  6. 6.
    Sakuma K, Saitoh N, Kasai M, et al. Relative risks of death due to liver disease among Japanese male adults having various statuses for hepatitis B s and e antigen/antibody in serum: A prospective study. Hepatology 1988;8:1642–1646.PubMedGoogle Scholar
  7. 7.
    Bruix J, Calvet X, Costa J, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989;II:1004–1006.Google Scholar
  8. 8.
    Columbo M, Kuo G, Choo QL, et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989;II:1004–1006.Google Scholar
  9. 9.
    Yu MC, Tong AJ, Cousaget P, et al. Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst 1990;82:1038–1041.PubMedGoogle Scholar
  10. 10.
    Kiyosawa K, Sodeyama T, Tanaka E, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 1990;12:671–675.PubMedGoogle Scholar
  11. 11.
    Nishioka K, Watanabe J, Furuta, S, et al. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 1991;67:429–433.PubMedGoogle Scholar
  12. 12.
    Tanaka K, Hirohata T, Koga S, et al. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res 1991;51:2842–2847.PubMedGoogle Scholar
  13. 13.
    Resnick RH, Koff R. Hepatitis C-related hepatocellular carcinoma: Prevalence and significance. Arch Int Med 1993;153:1672–1677.Google Scholar
  14. 14.
    Liver Cancer Study Group of Japan. Survey and follow-up study of primary liver cancer in Japan: Report 8 (in Japanese). Acta Hepatol Jap 1988;29:1619–1626.Google Scholar
  15. 15.
    Kalayci C, Johnson PJ, Davies SE, et al. Hepatitis B virus-related hepatocellular carcinoma in the non-cirrhotic liver. J Hepatol 1991;12:54–59.CrossRefPubMedGoogle Scholar
  16. 16.
    Tanaka T, Miyamoto H, Hino O, et al. Primary hepatocellular carcinoma with hepatitis B virus-DNA integration in a 4-year-old boy. Hum Pathol 1986;17:202–204.PubMedGoogle Scholar
  17. 17.
    Chang MH, Chen PJ, Chen JY, et al. Hepatitis B virus integration in hepatitis B virus-related hepatocellular carcinoma in childhood. Hepatology 1991;13:316–320.CrossRefPubMedGoogle Scholar
  18. 18.
    Ducreux M, Buffer C, Dussaix, et al. Antibody to hepatitis C virus in hepatocellular carcinoma. Lancet 1990;I:300–301.Google Scholar
  19. 19.
    Chiaramonte M, Farinati F, Faginoli S, et al. Antibody to hepatitis C virus in hepatocellular carcinoma. Lancet 1990;I:301–302.Google Scholar
  20. 20.
    Ikeda K, Saitoh S, Koida I, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993;18:47–53.CrossRefPubMedGoogle Scholar
  21. 21.
    Cox DR. Regression models and life tables. J R Stat Soc 1972; 34:248–275.Google Scholar
  22. 22.
    Kaplan EL, Meier P. Nonparametric estimation for incomplete observation. J Am Stat Assoc 1958;53:457–481.Google Scholar
  23. 23.
    Simonetti RG, Camma C, Fiorello F, et al. Hepatocellular carcinoma: A worldwide problem and the major risk factors. Dig Dis Sci 1991;36:962–972.CrossRefPubMedGoogle Scholar
  24. 24.
    Benvegnù, L, Fattovich G, Noventa F, et al. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. Cancer 1994;74:2442–2448.PubMedGoogle Scholar
  25. 25.
    Tanaka N, Chiba T, Matsuzaki Y, et al. High prevalence of Hepatitis B and C viral markers in Japanese patients with hepatocellular carcinoma. Gastroenterol Jpn 1993;28:547–553.PubMedGoogle Scholar
  26. 26.
    Galloway DA, McDougall JR. The oncogenic potential ofHerpes simplex viruses: evidence for a “hit and run” mechanism. Nature 1983;302:21–24.CrossRefPubMedGoogle Scholar
  27. 27.
    Paterlini P, Gerken G, Nakajima E, et al. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med 1990;323:80–85.PubMedGoogle Scholar
  28. 28.
    Kaneko S, Miller RH, Feinstone SM, et al. Detection of serum hepatitis B virus DNA in patients with chronic hepatitis using the polymerase chain reaction assay. Proc Natl Acad Sci USA 1989; 86:312–316.PubMedGoogle Scholar
  29. 29.
    Liang TJ, Baruch Y, Ben-Porath E, et al. Hepatitis B virus infection in patients with idiopathic liver disease. Hepatology 1991; 13:1044–1051.CrossRefPubMedGoogle Scholar
  30. 30.
    Luo KX, Zhou R, He C, et al. Hepatitis B virus DNA in sera of virus carriers positive exclusively for antibodies to the hepatitis B core antigen. J Med Virol 1991;35:55–59.PubMedGoogle Scholar
  31. 31.
    Sheu JC, Huang GT, Shih LN, et al. Hepatitis C and B virus in hepatitis B surface antigen-negative hepatocellular carcinoma. Gastroenterology 1992;103:1322–1327.PubMedGoogle Scholar
  32. 32.
    Ruiz J, Sangro B, Cuende JI, et al. Hepatitis B and C viral infections in patients with hepatocellular carcinoma. Hepatology 1992;16:637–641.PubMedGoogle Scholar
  33. 33.
    Paterlini P, Driss F, Nalpas B, et al. Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: A study of a low-endemic area. Hepatology 1993;17:20–29.CrossRefPubMedGoogle Scholar
  34. 34.
    Zhang YY, Hansson BG, Kuo LS, et al. Hepatitis B virus DNA in serum and liver is commonly found in Chinese patients with chronic liver disease despite the presence of antibodies to HBsAg. Hepatology 1993;17:538–544.PubMedGoogle Scholar
  35. 35.
    Nishioka K, Watanabe J, Furuta S, et al. Antibody to the hepatitis C virus in acute hepatitis and chronic liver diseases in Japan. Liver 1991;11:65–70.PubMedGoogle Scholar
  36. 36.
    Pares A, Barrera JM, Caballeria J, et al. Hepatitis C virus antibodies in chronic alcoholic patients: Association with severity of liver injury. Hepatology 1990;12:1295–1299.PubMedGoogle Scholar
  37. 37.
    Nalpas B, Driss F, Pol S, et al. Association between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver disease. J Hepatol 1991;12:70–74.CrossRefPubMedGoogle Scholar
  38. 38.
    Yamauchi M, Nakahara M, Maezawa Y, et al. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C. Am J Gastroenterol 1993;88:39–43.PubMedGoogle Scholar
  39. 39.
    Takase S, Tsutsumi M, Kawahara H, et al. Alcohol-altered liver membrane antibody and hepatitis C virus infection in the progression of alcoholic liver disease. Hepatology 1993;17:9–13.CrossRefPubMedGoogle Scholar
  40. 40.
    Takada A, Nei J, Takase S, et al. Effect of ethanol on experimental hepatocarcinogenesis. Hepatology 1986;6:65–72.PubMedGoogle Scholar
  41. 41.
    Schwarz M, Buchmann A, Wiesbeck G, et al. Effect of ethanol on early stages in nitrosamine carcinogenesis in rat liver. Cancer Lett 1983;20:305–312.CrossRefPubMedGoogle Scholar
  42. 42.
    Paglialo L, Simonetti RG, Craxi A, et al. Alcohol and HBV infection as risk factors for hepatocellular carcinoma in Italy: A multicentric, controlled study. Hepato-Gastroenterol 1983;30:48–50.Google Scholar
  43. 43.
    Villa E, Baldini GM, Pasquinelli C, et al. Risk factors for hepatocellular carcinoma in Italy. Male sex, hepatitis B virus, non-A, non-B infection, and alcohol. Cancer 1988;62:611–615.PubMedGoogle Scholar
  44. 44.
    Ohnishi K, Iida S, Iwana S, et al. The effect of chronic alcohol intake on the development of liver cirrhosis and hepatocellular carcinoma: Relation to hepatitis B surface antigen carriage. Cancer 1982;49:672–677.PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1996

Authors and Affiliations

  • Toshiya Chiba
    • 1
  • Yasushi Matsuzaki
    • 1
  • Masato Abei
    • 1
  • Junichi Shoda
    • 1
  • Tatsuya Aikawa
    • 2
  • Naomi Tanaka
    • 1
  • Toshiaki Osuga
    • 1
  1. 1.Department of Medicine, Institute of Clinical MedicineUniversity of TsukubaTsukuba, IbarakiJapan
  2. 2.Aikawa HospitalMito, IbarakiJapan

Personalised recommendations